INSM Jan 2025 42.500 call
| Previous Close | 26.17 |
| Open | 26.17 |
| Bid | 33.20 |
| Ask | 38.00 |
| Strike | 42.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 26.17 - 26.17 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
GuruFocus.comInsmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Insmed Inc (INSM) reports robust financial performance and outlines strategic initiatives for upcoming product launches amid competitive challenges.
ZacksInovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
Inovio (INO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PR NewswireNew Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today presented positive late-breaking subgroup data from the Phase 3 ASPEN study, a global, randomized, double-blind, placebo-controlled Phase 3 study to assess the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis bronchiectasis. Posters with the details from th
